U.S. Insurance Stock News

In recent quarters, AAON, Inc. has sharply raised its 2026 revenue growth outlook as its BASX division becomes a central driver of demand for AI-focused data center cooling solutions. An interesting twist is that BASX now contributes nearly half of AAON’s revenue, underpinned by a very large backlog of AI-related data center orders that reshapes the company’s business mix. We’ll now examine how AAON’s upgraded growth outlook, powered by BASX’s AI data center cooling momentum, influences the...

If you are wondering whether Teva Pharmaceutical Industries at US$33.31 is still offering value or has already run too far, this article will help you frame that question clearly. Over the past week the stock is up 3.4%, while it is down 5.7% over the last month, with returns of 7.6% year to date and 98.7% over the past year adding important context for anyone weighing the balance of opportunity and risk. Recent coverage of Teva Pharmaceutical Industries has focused on its role within the...

The market remained flat over the last week, but over the past 12 months, it has risen by 20%, with earnings expected to grow by 19% per annum in the coming years. In this environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability to capitalize on these positive market trends.

If you are wondering whether EMCOR Group at around US$814 a share is still offering good value or has run too far ahead, this article walks through the numbers in a clear, practical way. The stock has had a mixed short term pattern, with the share price down 6.3% over the past week and down 1.5% over the past month, while still showing a 27.5% gain year to date and a 52.5% return over the last year. Recent coverage has focused on EMCOR Group's position within the construction and capital...

AbCellera Biologics (ABCL) is back in focus after announcing a preclinical collaboration with Jazz Pharmaceuticals. The partnership aims to discover next generation T cell engaging multispecific antibodies for gastrointestinal cancers and other solid tumors. See our latest analysis for AbCellera Biologics. The Jazz collaboration press release coincides with sharp share price momentum for AbCellera Biologics, with a 1 day share price return of 10.03% and a 7 day gain of 44.23%. That short term...

In the last week, the United States market has stayed flat, but it is up 20% over the past year with earnings expected to grow by 19% annually in the coming years. In this environment, identifying undervalued stocks—those trading below their intrinsic value—can offer potential opportunities for investors seeking to capitalize on future growth prospects.

Arista Networks (NYSE:ANET) has been added to the Russell Top 50 Index, reflecting its current scale in the US equity market. A new Dell'Oro Group report highlights accelerated growth expectations for Public Cloud-managed LAN through 2030, with Arista cited as a vendor expanding features in this segment. Arista Networks enters this news cycle with its stock at $164.1 and a very large 5 year return, alongside a 60.4% return over the past year and 22.8% return year to date. Inclusion in the...

A civil antitrust lawsuit has been filed against Micron Technology, Samsung, and SK hynix alleging coordinated memory production cuts during the AI-driven chip shortage. The case claims the companies restricted supply to keep prices elevated for DRAM and NAND products. The litigation revives scrutiny of Micron's pricing conduct in light of its historical involvement in a 2002 price-fixing scandal. Micron Technology, traded as NasdaqGS:MU, sits at the center of the AI infrastructure...

In the last week, the market has stayed flat, but it is up 20% over the past year with earnings forecast to grow by 19% annually. While penny stocks may seem like a relic from past market eras, they continue to offer unique opportunities for growth, particularly in smaller or newer companies. When these stocks are backed by strong financial health and solid fundamentals, they can present an attractive mix of affordability and potential upside.

The United States market remained flat over the last week but has experienced a significant 20% increase over the past year, with earnings expected to grow by 19% annually. In this context, growth companies with high insider ownership can be particularly appealing as they often indicate strong internal confidence and alignment of interests between management and shareholders.

Over the last 7 days, the United States market has remained flat, yet it has shown a robust 20% increase over the past year. In this context of steady growth and promising earnings projections, dividend stocks like Euroseas can offer investors a reliable income stream while potentially benefiting from capital appreciation.

Index removal puts Asbury Automotive Group in focus Asbury Automotive Group (ABG) was removed from the Russell 2000 Dynamic Index on June 27, an index change that can influence trading flows as index funds and institutions rebalance holdings. For you as an investor, this type of event raises practical questions about how index-related selling or reallocation might intersect with Asbury Automotive Group’s current fundamentals, recent share performance and valuation signals. See our latest...

Geopolitical shocks in the Middle East and a brief halt to shipping in the Strait of Hormuz have put global shipping and logistics stocks back in the spotlight. With U.S. and Iran talks in Qatar, a ceasefire in place and oil and gas prices easing after recent tension, some companies exposed to this news now sit at an interesting crossroads. For investors watching how trade routes, freight flows and energy costs react to these events, this article walks through 3 stocks from our Global...

Why Stagwell’s Index Additions Matter for Investors Stagwell (STGW) was recently added to multiple Russell value benchmarks, including the Russell 2000 Value and Russell 3000 Value indices, an event that can reshape how many institutional investors gain exposure to the stock. See our latest analysis for Stagwell. Stagwell’s recent inclusion in several Russell value indices comes after a strong year to date, with a 47.15% year to date share price return and a 54.67% 1 year total shareholder...

Lamar Advertising Company (NasdaqGS:LAMR) was recently added to multiple Russell value and defensive indices, including the Russell 1000 Value, Russell 3000 Value, Russell Midcap Value, and related benchmarks, while being removed from the Russell 1000 Dynamic Index. This broad shift into value- and defense-oriented indices highlights how the market is classifying Lamar’s business profile and risk characteristics relative to peers. We’ll now explore how Lamar’s expanded presence in Russell...

In June 2026, Lazard, Inc. filed a shelf registration for up to 45,000,000 shares of common stock, totaling about US$2.02 billion, in connection with an ESOP-related offering. This filing signals a potentially meaningful change in Lazard’s capital structure, with implications for ownership dilution and how the firm funds employee participation. We’ll now examine how this sizeable ESOP-related shelf registration could influence Lazard’s existing investment narrative and future capital...

East West Bancorp (EWBC) has attracted attention after recent share price moves, prompting investors to reassess how its current valuation lines up with the bank’s earnings profile, balance sheet strength, and longer term return record. See our latest analysis for East West Bancorp. At a latest share price of $129.09, East West Bancorp’s short term share price return has softened slightly over the past week. However, the 30 day and 90 day share price returns of 5.35% and 18.07% sit alongside...

In recent commentary about Peoples Bancorp, analysts highlighted concerns that past revenue growth has been muted, net interest margin has slipped, and earnings per share have barely improved over the last two years. These trends have prompted questions about how effectively the bank is converting its balance-sheet expansion into higher profitability. We will now examine how these worries about Peoples Bancorp’s slowing revenue momentum and net interest margin pressure shape its investment...

In late June 2026, UDR, Inc. was removed from several Russell growth indices and added to the broader Russell 2500 and Russell 2500 Value benchmarks, signaling a reclassification toward value within the small-to-mid-cap universe. At the same time, management’s move to shift UDR’s dividend to a monthly schedule from July 2026 underscores a focus on consistent income and may influence how income-oriented investors view the stock. We’ll now explore how UDR’s shift from growth to value indices,...

Niagen Bioscience (NAGE) has been drawing attention after its recent rebranding from ChromaDex Corporation, shifting investor focus toward its healthy aging product portfolio and proprietary NIAGEN ingredient as the stock reacts to this corporate transition. See our latest analysis for Niagen Bioscience. Recent trading has been weaker for Niagen Bioscience, with the share price at about US$3.30 after declining around 15% over the past month and about 47% year to date. The 3 year total...

Diebold Nixdorf (DBD) has just been shifted across several Russell indexes, dropped from multiple value benchmarks, and added to defensive and growth defensive groupings, a reshuffle that can influence fund flows and trading activity. See our latest analysis for Diebold Nixdorf. That reshuffle has come alongside firm share price momentum for Diebold Nixdorf, with the stock closing at US$83.45 and recording a 30.47% year to date share price return and a 50.63% total shareholder return over the...

The Supreme Court’s decision to uphold birthright citizenship removes a major source of uncertainty for millions of families and the employers that rely on them. For investors, clearer immigration rules can mean steadier labor supply and more predictable consumer demand, which can matter as much as any earnings report. This article looks at three stocks exposed to this ruling through their dependence on immigrant workers or diverse customer bases. Each one could see business conditions shaped...

Sigma Lithium recently attracted attention after analysts projected very large year-over-year EPS and revenue increases for its latest reported quarter, supported by a valuation seen as favorable relative to the broader metals and mining sector. The company’s Zacks Rank of #1 (Strong Buy) highlights how strongly analyst sentiment has shifted, underscoring expectations for improved near-term business performance. We’ll now examine how the anticipated earnings jump and favorable analyst stance...

Xylem recently expanded its water treatment offerings through commercial partnerships with Gross-Wen Technologies for integrated industrial wastewater solutions and with Moleaer to introduce nanobubble technology to surface water restoration projects, while also announcing executive leadership changes effective July 1, 2026, including new EVP roles for Measurement and Control Solutions and Applied Water. These moves highlight Xylem’s emphasis on higher-value treatment technologies and...